Author name: Leonardo Arias

The U.S. alleged the company knowingly sold genetic-sequencing systems with software vulnerabilities to federal agencies.

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 per share.

Women and pediatricians were likely to receive lower compensation relative to their peers, according to Doximity’s 2025 physician compensation report.

According to reporting from multiple outlets, Richard Pazdur, head of the Oncology Center of Excellence at CDER, opposed the consensus opinion of CBER staff to approve the drug. Replimmune’s stock has dropped precipitously since the rejection.

The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of around 20% but that pricing and Comirnaty’s market share will hold steady.

Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration, to include anti-obesity medications in Medicare Part D coverage.

The pivotal Phase II trial is testing Allogene’s CAR T candidate cemacabtagene ansegedleucel for large B-cell lymphoma. ALLO-647 was being used as a preparative lymphodepletion therapy.

Unos científicos han desarrollado una innovadora estrategia computacional, mediante inteligencia artificial, que permite diseñar moléculas terapéuticas desde cero, incluso disponiendo de datos experimentales limitados. Y ya la han puesto a prueba con éxito, dise&nt …

Noticias de la actualidad astronómica y astronáutica del 4 de agosto de 2025.     …

En un nuevo estudio, se ha analizado el impacto de la desinformación digital en procesos electorales tanto en España como en Portugal. El informe revela una creciente preocupación social por la manipulación informativa, pero también muestra el alto grado de escepti …